Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene [2]

Acta Dermato-Venereologica

Volumn 85, Issue 4, 2005, Pages 346-348

  Cotellessa, Claudia ^a   Cuevas Covarrubias, Sergio A ^b   Valeri, Patrizia ^a   Fargnoli, Maria Concetta ^a   Peris, Ketty ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GLYCOLIC ACID; STERYL SULFATASE; TAZAROTENE; VALPROIC ACID;

ADULT; CASE REPORT; CLINICAL FEATURE; DNA FLANKING REGION; ENZYME ACTIVITY; EPILEPSY; ERYTHEMA; EXON; FOLLOW UP; GENE; GENE DELETION; HUMAN; ICHTHYOSIS; LETTER; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRURITUS; REMISSION; STS GENE; SYMPTOM;

ADMINISTRATION, CUTANEOUS; ADULT; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; GLYCOLATES; HUMANS; ICHTHYOSIS, X-LINKED; MALE; NICOTINIC ACIDS; STERYL-SULFATASE;

EID: 23444436515     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550510026613     Document Type: Letter

References (15)

1. Hernandez-Martin A, Gonzales-Sarmiento R, Unamuno P. X-linked ichthyosis: an update. Br J Dermatol 1999; 141: 617-627.
2. Shapiro LJ, Weiss R, Webster D, France JT. X-linked ichthyosis due to a steroid sulphatase deficiency. Lancet 1978; 14: 70-72.
3. Ballabio A, Carrozzo R, Parenti G, Gil A, Zollo M, Persico MG, et al. Molecular heterogeneity of steroid sulfatase deficiency: a multicenter study on 57 unrelated patients, at DNA and protein levels. Genomics 1989; 4: 36-40.
4. Jimenez Vaca AL, Valdes-Flores Mdel R, Rivera-Vega MR, Gonzalez-Huerta LM, Kofman-Alfaro SH, Cuevas-Covarrubias SA. Deletion pattern of the STS gene in X-linked ichthyosis in a Mexican population. Mol Med 2001; 7: 845-849.
5. Saeki H, Kuwata S, Nakagawa H, Shimada S, Tamaki K, Ishibashi Y. Deletion pattern of the steroid sulphatase gene in Japanese patients with X-linked ichthyosis. Br J Dermatol 1998; 139: 96-98.
6. Blanchet-Bardon CI, Nazarro V, Rognus C. Acitretin in the treatment of severe disorders of keratinization. Results of an open study. J Am Acad Dermatol 1991; 24: 982-986.
7. Hoffmann B, Stege H, Ruzicka T, Lehmann P. Effect of topical tazarotene in the treatment of congenital ichthyoses. Br J Dermatol 1999; 141: 642-646.
8. Ingordo V, D'Andria G, Gentile C, Decuzzi M, Mascia E, Naldi L. Frequency of X-linked ichthyosis in coastal southern Italy: a study on a representative sample of a young male population. Dermatology 2003; 207: 148-150.
9. Zettersten E, Mao-Quang M, Sato J, Denda M, Farrell A, Ghadially R, et al. Recessive X-linked ichthyosis: role of cholesterol-sulphate accumulation in the barrier abnormality. J Invest Dermatol 1998; 111: 784-790.
10. Morita E, Katoh O, Shinoda S, Hiragun T, Tanaka T, Kameyoshi Y, et al. A novel point mutation in the steroid sulfatase gene in X-linked ichthyosis. J Invest Dermatol 1997; 109: 244-245.
11. Ballabio A, Bardoni B, Carrozzo R, Andria G, Bick D, Campbell L, et al. Contiguous gene syndromes due to deletions in the distal short arm of the human X chromosome. Proc Natl Acad Sci 1989; 86: 10001-10005.
12. Watanabe T, Fujimori K, Kato K, Nomura Y, Onogi S, Sato A. Prenatal diagnosis for placental steroid sulfatase deficiency with fluorescence in situ hybridization: a case of X-linked ichthyosis. J Obstet Gynaecol Res 2003; 29: 427-430.
13. Van Scott EJ, Yu RJ. Hyperkeratinization, corneocyte cohesion and alpha hydroxy acids. J Am Acad Dermatol 1984; 11: 867-879.
14. Di Nardo J, Grove GL, Moy LS. Clinical and histological effects of glycolic acid at different concentrations and pH levels. Dermatol Surg 1996; 22: 421-424.
15. Duvic M, Helekar B, Schulz C, Cho M, DiSepio D, Hager C, et al. Expression of a retinoid-inducible tumor suppressor, tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res 2000; 6: 3249-3259.